Prof. Ahmed Assaf on Patient Selection and Optical Design with WELL Fusion® and EVOLUX® IOLs | SIFI
In this testimonial, Prof. Ahmed Assaf (Egypt) discusses how he selects ideal candidates for the WELL Fusion® and EVOLUX® IOLs…
Neurotech CEO Rich Small on ENCELTO™ and Redefining Retinal Cell-Based Gene Therapy | Eyecelerator 2025
At Eyecelerator 2025, Neurotech CEO Rich Small shares the story behind ENCELTO™, a first-in-class encapsulated cell-based gene therapy for the…
popular posts
latest posts
